13F HOLDINGS REPORT
Bain Capital Life Sciences Investors, LLC
Quarter ended Q2 2024 · Filed August 12, 2024 · Accession 0000950123-24-007830
Total Value
$910.8M
Positions
25
Other Managers
11
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NUVALENT INC | NUVL | 2,697,267 | $204.6M | 22.46% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 10,473,913 | $201.2M | 22.09% |
| 3 | DISC MEDICINE INC | IRON | 1,795,735 | $80.9M | 8.89% |
| 4 | DIANTHUS THERAPEUTICS INC | DNTH | 3,013,423 | $78.0M | 8.56% |
| 5 | PHARVARIS N V | PHVS | 3,303,381 | $62.1M | 6.82% |
| 6 | SAVARA INC | SVRA | 14,565,457 | $58.7M | 6.44% |
| 7 | ANNEXON INC | ANNX | 8,449,208 | $41.4M | 4.55% |
| 8 | KYVERNA THERAPEUTICS INC | KYTX | 3,368,370 | $25.3M | 2.77% |
| 9 | TANGO THERAPEUTICS INC | TNGX | 2,892,663 | $24.8M | 2.72% |
| 10 | SOLID BIOSCIENCES INC | SLDB | 4,034,582 | $22.9M | 2.51% |
| 11 | MERSANA THERAPEUTICS INC | 59045L106 | 8,663,673 | $17.4M | 1.91% |
| 12 | SYROS PHARMACEUTICALS INC | 87184Q206 | 2,749,808 | $14.2M | 1.56% |
| 13 | CENTURY THERAPEUTICS INC | IPSC | 5,410,361 | $13.8M | 1.51% |
| 14 | CABALETTA BIO INC | CABA | 1,649,964 | $12.3M | 1.35% |
| 15 | X4 PHARMACEUTICALS INC | XFOR | 16,915,784 | $9.8M | 1.08% |
| 16 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 1,030,703 | $9.6M | 1.05% |
| 17 | ATEA PHARMACEUTICALS INC | AVIR | 2,485,638 | $8.2M | 0.90% |
| 18 | RAPID MICRO BIOSYSTEMS INC | RPID | 8,434,560 | $5.6M | 0.61% |
| 19 | C4 THERAPEUTICS INC | CCCC | 1,111,910 | $5.1M | 0.56% |
| 20 | NAUTILUS BIOTECHNOLOGY INC | NAUT | 2,000,000 | $4.7M | 0.51% |
| 21 | XILIO THERAPEUTICS INC | XLO | 3,785,450 | $3.6M | 0.39% |
| 22 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 2,267,680 | $2.7M | 0.29% |
| 23 | INVIVYD INC | IVVD | 1,799,595 | $2.0M | 0.22% |
| 24 | ACLARIS THERAPEUTICS INC | ACRS | 1,000,000 | $1.1M | 0.12% |
| 25 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 100,000 | $872,000 | 0.10% |